April 01, 2008; 70 (14) Articles
New VAPB deletion variant and exclusion of VAPB mutations in familial ALS
J. E. Landers, A. L. Leclerc, L. Shi, A. Virkud, T. Cho, M. M. Maxwell, A. F. Henry, M. Polak, J. D. Glass, T. J. Kwiatkowski, A. Al-Chalabi, C. E. Shaw, P. N. Leigh, I. Rodriguez-Leyza, D. McKenna-Yasek, P. C. Sapp, R. H. Brown
First published March 5, 2008, DOI: https://doi.org/10.1212/01.wnl.0000289760.85237.4e
J. E. Landers
A. L. Leclerc
L. Shi
A. Virkud
T. Cho
M. M. Maxwell
A. F. Henry
M. Polak
J. D. Glass
T. J. Kwiatkowski
A. Al-Chalabi
C. E. Shaw
P. N. Leigh
I. Rodriguez-Leyza
D. McKenna-Yasek
P. C. Sapp
New VAPB deletion variant and exclusion of VAPB mutations in familial ALS
J. E. Landers, A. L. Leclerc, L. Shi, A. Virkud, T. Cho, M. M. Maxwell, A. F. Henry, M. Polak, J. D. Glass, T. J. Kwiatkowski, A. Al-Chalabi, C. E. Shaw, P. N. Leigh, I. Rodriguez-Leyza, D. McKenna-Yasek, P. C. Sapp, R. H. Brown
Neurology Apr 2008, 70 (14) 1179-1185; DOI: 10.1212/01.wnl.0000289760.85237.4e
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 70 no. 14 1179-1185
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published March 5, 2008.
Article Versions
- Previous version (March 5, 2008 - 12:51).
- You are viewing the most recent version of this article.
Copyright & Usage:
© 2008
Author Disclosures
- J. E. Landers, PhD,
- A. L. Leclerc, BA,
- L. Shi, MD,
- A. Virkud,
- T. Cho, BS,
- M. M. Maxwell, PhD,
- A. F. Henry, BS,
- M. Polak, RN,
- J. D. Glass, MD,
- T. J. Kwiatkowski, MD,
- A. Al-Chalabi, PhD, FRCP,
- C. E. Shaw, MD, FRACP,
- P. N. Leigh, FRCP, PhD,
- I. Rodriguez-Leyza, MD,
- D. McKenna-Yasek, RN, BSN,
- P. C. Sapp, BS and
- R. H. Brown Jr, MD, DPhil
- J. E. Landers, PhD,
- A. L. Leclerc, BA,
- L. Shi, MD,
- A. Virkud,
- T. Cho, BS,
- M. M. Maxwell, PhD,
- A. F. Henry, BS,
- M. Polak, RN,
- J. D. Glass, MD,
- T. J. Kwiatkowski, MD,
- A. Al-Chalabi, PhD, FRCP,
- C. E. Shaw, MD, FRACP,
- P. N. Leigh, FRCP, PhD,
- I. Rodriguez-Leyza, MD,
- D. McKenna-Yasek, RN, BSN,
- P. C. Sapp, BS and
- R. H. Brown Jr, MD, DPhil
- From Cecil B. Day Laboratory for Neuromuscular Research (J.E.L., A.L.L., L.S., A.V., T.C., M.M.M., A.F.H., T.J.K., I.R.-L., D.M.-Y., P.C.S., R.H.B.), Massachusetts General Hospital East, Charlestown; Center for Neurodegenerative Disease (M.P., J.D.G.), School of Medicine, Emory University, Atlanta, GA; MRC Centre for Neurodegeneration Research (A.A.-C., C.E.S., P.N.L.), King’s College London, Institute of Psychiatry, Department of Neurology, London, UK; Department of Neurology (I.R.-L.), Hospital Central, Colonia Universitaria, San Luis Potosi, Mexico; and Howard Hughes Medical Institute (P.C.S.), Department of Biology, Massachusetts Institute of Technology.
- Address correspondence and reprint requests to Dr. J. Landers, MGH East, Room 3216, Bldg. 149, 13th Street, Charlestown, MA 02129 jelanders{at}partners.org
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.